Search results
Deal or No Deal Island Finale: Who Will Win?
COMINGSOON.net via Yahoo News· 7 days agoAfter watching Part 1 of the Deal or No Deal Island finale, many fans have been left wondering who will win the show. The episode ended on a cliffhanger...
Shionogi secures licence for Maze’s Pompe disease treatment
Pharmaceutical Technology via Yahoo Finance· 5 days agoShionogi has concluded an exclusive global licence agreement forMaze Therapeutics’ MZE001, an oral...
Artist Jules Wittock reveals the hidden secret to his mesmerising maze pantings
Creative Bloq via Yahoo News· 7 days agoBut there's not laptop for drawing in sight and an Adobe app to call on, this artist creates elegant...
Maze lands new partner for Pompe drug, after Sanofi pact came apart
BioPharma Dive via Yahoo Finance· 5 days agoDive Brief: Biotechnology startup Maze Therapeutics has licensed a Pompe disease drug to Shionogi,...
3 Small-Cap Stocks With Massive Growth Potential in the Next Year
InvestorPlace· 16 hours agoNavigating the complex maze of trends and statistics is key to uncovering profitable investment opportunities. To begin with, the first company’s solid dividend policy and ...
Outbreak Perfected Exotic quest, Zero Hour guide - Destiny 2
Shacknews· 1 hour agoZero Hour returns to Destiny 2, giving players another means of acquiring Outbreak Perfected. This...
How Filmmaker Wes Ball Conquered the ‘Kingdom of the Planet of the Apes’
The Wrap via Yahoo News· 5 days agoThe "Maze Runner" director tells TheWrap about his initial hesitation to tackle the franchise and...
New report from Pence details threats from regulatory state
The Washington Times· 10 hours agoLet’s also consider “Rise of the Regulatory State: The Growing Maze of Red Tape Straining Our...
AI Can Do Paperwork Doctors Hate
Reason.com via Yahoo News· 21 hours agoAfter navigating a maze of scheduling hurdles, patients find themselves waiting 26 days on average to see a physician in major cities. The whole ordeal...
After FTC stalled Sanofi deal, Shionogi secures Maze's Pompe disease drug for $150M
FierceBiotech· 5 days agoIt appears Sanofi’s loss is Shionogi’s gain. Five months after the Federal Trade Commission (FTC) scuttled Sanofi’s attempt to acquire Maze Therapeutics’ Pompe disease program, Japan’s Shionogi has scooped up the asset.
